Trial Identifier: | D419QC00002 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02937818 |
Start Date: | November 2016 |
Primary Completion Date: | June 2020 |
Study Completion Date: | November 2023 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English version | |
German Translation | |
Hungarian Translation | |
Polish Translation | |
Russian Translation | |
Spanish Translation |
Country | Location |
---|---|
DE | Gauting, DE, 82131 |
ES | Sevilla, ES, 41009 |
ES | Valencia, ES, 46009 |
HU | Kecskemét, HU, 6000 |
HU | Miskolc, HU, 3529 |
HU | Székesfehérvár, HU, 8000 |
HU | Törökbálint, HU, 2045 |
PL | Poznań, PL, 60-569 |
PL | Warszawa, PL, 02-781 |
UA | Dnipro, UA, 49102 |
UA | Ivano-Frankivsk, UA, 76018 |
UA | Sumy, UA, 40022 |